Bariatric Surgery at 16

Last fall, Alexandra Duarte, who is now 16, went to see her endocrinologist at Texas Children’s Hospital, outside Houston. From age 10, she had been living with polycystic ovary syndrome and, more recently, prediabetes. After Alexandra described her recent quinceañera, the doctor brought up an operation that might benefit her, one that might help her lose weight and, as a result, improve these obesity-related problems.Listen to This ArticleOpen this article in the New York Times Audio app on iOS.Alexandra, who smiles shyly and speaks softly but confidently, says she was “a little skeptical at first because, like, it’s a surgery.” But her mother, Gabriela Velez, suggested that her daughter consider it. “Ever since I was a toddler, my mom knew that I was struggling with obesity,” Alexandra says.Through the years, Alexandra seemed to have tried everything. She went through periods when she avoided all carbs and days when she drank only water. She turned to commercial products, from Herbalife to diet pills to meal-replacement shakes. Desperation — and hope — led her to try gimmicky lotions that promised to burn fat. Puberty seemed to make things worse. Her doctors dispensed “basically the same talk everyone else gives me,” she says: Follow the government’s MyPlate plan; eat lots of vegetables; have anything, but don’t overdo it.Her mother diligently prepared her meals, cooking vegetables in ways that she liked. Alexandra herself worked on “getting fuller on less,” trying to limit each meal to a single plateful. Almost everyone in her immediate family carries extra weight — including her younger twin brothers, who put on more weight during the pandemic — but neither her father nor the twins nor another brother copied her efforts. Seeing them eat ice cream and cake made her vegetables less enticing. “I have a huge sweet tooth,” she says.The teasing started in fifth grade. Alexandra couldn’t eat without her classmates staring at and judging her. Though she sought counseling for her sadness and anxiety, these troubles still caused her to leave school for a month. The bullying finally stopped after she switched schools in 10th grade, but Alexandra’s parents knew how deeply she continued to suffer. How much more could their daughter endure? After the doctor suggested bariatric surgery, an operation on the gastrointestinal tract that helps patients lose weight, they spoke to friends who had successfully been through the procedure as adults. They decided it was a smart option for her. Alexandra wasn’t sure, however.When the family met the surgeon, Jose Ruben Rodriguez, he was quick to tell them that the operation was no “shortcut.” Indeed, Alexandra first had to complete the hospital’s strict, comprehensive behavior and lifestyle program, which lasts six to nine months; this effort would demonstrate her commitment to improving her health while also preparing her for surgery and life afterward. Many teenagers find this step too challenging: Rodriguez estimates that less than one-third of them end up receiving the surgery after their initial appointment. For Alexandra, the program’s tasks mimicked what she had tried already: keeping food journals, drinking more water, setting sleep schedules (which in turn often means restricting access to phones). She was also instructed to exercise; as someone who loves dancing to K-pop songs in her bedroom and going to the gym with friends, Alexandra didn’t find that difficult, either. “I guess for some people it could be intense,” she says, “but it honestly to me felt a little bit easy.”Alexandra also saw a dietitian, a psychologist, a gynecologist and a social worker. She was tested too: blood draws, ultrasound, X-rays, sleep study. With each appointment, she felt increasingly comfortable with the prospect of an operation. It was especially helpful to hear Rodriguez explain the procedure, called a sleeve gastrectomy, and describe the experiences of other teenagers who had been through it. After several months of deliberating, she decided to go ahead. The other would-be fixes “never really solved the problem,” Alexandra says. “No matter how many pounds I lose, I gain it back. And it’s sometimes even more. It made me feel discouraged with my efforts, like maybe I wasn’t trying hard enough.”Alexandra before her bariatric surgery at Texas Children’s Hospital.Helen OuyangAlexandra is one of the roughly 20 percent of children in the United States living with obesity, up from 5 percent in the 1970s. Another 16 percent or so are considered overweight. The prevalence of obesity increases as children get older: to more than 22 percent among adolescents from around 13 percent in 2-to-5-year-olds. At 5-foot-1 and 209 pounds, Alexandra had a body mass index that placed her well above the threshold for severe obesity, which is 120 percent of the 95th percentile, according to the C.D.C.’s Extended B.M.I.-for-Age Growth Chart. Without treatment, Alexandra would almost inevitably have obesity into adulthood. And the longer that continued, the more at risk she would be for chronic health issues, like joint pain and problems with breathing and sleeping. Worse, some children in her situation can develop what were once considered adult illnesses: hypertension, diabetes, fatty liver disease. Obesity can also magnify mental-health problems. Teenagers with obesity are more likely than those without obesity to contemplate suicide.Severe obesity is the fastest-rising subcategory among youth — “an epidemic within an epidemic,” as the American Academy of Pediatrics calls it. During the pandemic, the rate of increase in children’s B.M.I. doubled; the greatest gains were in those who were already overweight. Worldwide, the rates of pediatric obesity, which is not solely an American affliction, could double by 2035.In response to so many grim facts, the A.A.P. in January released its first “clinical practice guideline” for those who care for children who have obesity. The academy now recommends that they immediately start “intensive health behavior and lifestyle treatment,” which it labels “the foundation” of obesity management; this approach supersedes the former strategy of “watchful waiting.” For older youth in certain circumstances — those with a higher B.M.I., say — drugs and, in cases of severe obesity, surgery should be made available as options. “The guideline supports what the evidence supports,” Sarah Hampl, its lead author, told me, when she described the yearslong review process. “We didn’t go beyond that.”Semaglutide, one of the newest drugs being used for weight loss, was approved for adolescents 12 and older at the end of December, shortly before the A.A.P. guidelines were released. (Ozempic is the brand name of one semaglutide formulation that has dominated headlines and social media for its off-label use in helping adults swiftly and effortlessly shed pounds.) The drugs seem to offer a promising remedy, though it is too early to know if their use among adolescents will be as widespread. Also, it is unclear if the drugs will be sufficient to treat severe obesity; for now, surgery, a treatment of longer standing whose rates have increased substantially among teenagers over the last decade, remains the most effective intervention for them. As soon as the recommendations were announced, they were met with fierce criticism for their screening and treatment methods, especially drugs like semaglutide and the surgery Alexandra opted for. Critics claimed that these approaches are far too aggressive and subject children’s bodies to unnecessary scrutiny and manipulation, potentially distorting how they view themselves, and that treatments could lead to eating disorders that cause more damage than obesity itself. Some critics challenged B.M.I. — a controversial measurement — and argued that doctors should not be diagnosing obesity in children at all. But, Hampl emphasizes, “the decision for treatment is really in the hands of the families,” rather than the doctors.In June, grasping her white stuffed puppy with floppy ears and her red blanket printed with gray hedgehogs, Alexandra waited in the pre-op area. She was nervous, but “not as nervous as she is,” she said, pointing to her mother. Gabriela nodded and said, “I think I’m thinking too much.” Alexandra’s father sat quietly beside her as she tried to keep busy by drawing in her sketchbook, eventually burying her face in her stuffed animal. The tenacity of body weight can be traced to our biology. Humans evolved to resist losing body fat so that we don’t become extinct, says Rudolph Leibel, chief of the pediatric molecular genetics division at Columbia University’s medical center. Scientists are still trying to unravel that evolutionary process. According to the “thrifty gene” hypothesis, which has been around for over a half-century, we gain weight (and keep it on) to help us prepare for and survive periodic famines. In 2008, John Speakman, an eminent British biologist, coined the “drifty gene” hypothesis: As human survival came to depend less on escaping predators, random gene mutations allowed our upper weight limits to drift higher. Today our brains may be regulating our body weight so that it stays within a range between upper and lower thresholds — while perhaps fighting harder to keep us above the bottom one. After all, starvation poses more immediate danger than obesity. “You cannot get a person to chronically defend a lower level of body fat by chronically restricting their calories,” Leibel says. But, he adds, that level may be pushed up “by virtue of environment.”Our brains are “nonconsciously defending that higher weight,” Stephan Guyenet, a neurobiologist and the author of “The Hungry Brain,” told me — and they are even capable of slowing down our metabolism to that end. The hypothalamus, seated deep in our brains, is the master of this tightly regulated system. Cone-shaped and no larger than an almond, it’s involved in determining if we’re hungry and accordingly prompts us to increase our food intake, or if we’re satisfied, decrease it. It also helps control our metabolism. The hypothalamus responds to signals sent from parts of the body including our fat cells and guts — signals like leptin, an important hormone that Leibel helped discover, which increases when body fat rises, telling our brains to stop eating. A small number of children with severe obesity are born with leptin deficiency, a gene mutation identified by Sadaf Farooqi, a professor at the University of Cambridge’s Institute of Metabolic Science. Their appetites seem to be bottomless. Though it’s rare, Farooqi cites the extreme effect of this mutation as a clear illustration of the “very strong” impact that biology has upon appetite. When Farooqi treated children with this deficiency by injecting them with leptin, they reduced their consumption; too much leptin made them stop eating entirely. “We can literally control how much they’re eating by the dose of leptin we’re giving them,” she says. In other words, appetite is not entirely within our conscious control or willpower. Ghrelin, a hunger hormone, increases when food intake is restricted, making us eat more. Insulin, another important hormone, helps turn the food we eat into energy and controls things like blood sugar that influence how much we eat.“Hunger is absolutely instinctual,” Guyenet told me. “We don’t decide whether we’re going to be hungry or not, whether we’re going to have a craving or not.” And while we might be able to control our intake for a meal or a week, we probably can’t do so every time we eat, for a lifetime. Even our brain’s reward system, which interacts closely with the hypothalamus, motivates us to seek high-calorie food. “There’s just a lot of different ways your brain can kind of sneak calories,” he says. “These regulatory systems have their tendrils everywhere.” A new, 12-year-old patient at Dr. Whitney Herring’s pediatric obesity clinic in Madison, Miss., holding a plate with sections for various food groups, represented by silicone examples. The plates help families manage portion sizes for balanced meals.Kholood Eid for The New York TimesGenetics may determine more than 70 percent of children’s body weight. Single-gene mutations are extremely rare (the most common one affects up to 5 percent of children with severe obesity); Farooqi says that nearly all children with obesity are living with the “cumulative effect of many different genetic variants, resulting in a bigger appetite.” So far, about 1,000 have been identified, most of which act on appetite and hunger, and there are probably many thousands more. Each variant might have a very slight impact — the strongest might be responsible for one person being five pounds heavier than the next — but, Farooqi says, “when you add them up together, they probably explain why some people are much more likely to get obese than others.” But if our genes didn’t change significantly in the last century, why, then, are children getting bigger? No one knows for sure. One likely explanation, however, is the evolutionary mismatch between our genes and our surroundings. Children who end up with obesity were always at the highest genetic risk for that outcome, even if it wasn’t certain to develop, but now, Farooqi says, “the environment is likely unmasking their genetic susceptibility.” The most substantial transformation in their surroundings has been to the food they eat, which in the past was different in its composition and far more limited. Leibel refers to “a revolution in human environments” and notes that our genes haven’t changed “fast enough to accommodate something that’s really an invention of the past 75 years.” The amount of readily accessible food has expanded immensely, making it easier than ever to eat — open a phone app, say, or go to a drive-through. Plenty of Americans can consume as much as they want, whenever they want. Today nearly 70 percent of what children eat is ultraprocessed food, which the NOVA classification system, a commonly used framework, defines as having been formulated from “ingredients mostly of exclusive industrial use, typically created by series of industrial techniques and processes” — which makes them extremely flavorful. These foodstuffs include things our great-grandparents would not have consumed: packaged chips, energy drinks, ready-to-heat-and-eat meals. They are thought to be an important driver of the childhood-obesity epidemic, in part because they seem to make us eat more. Kevin Hall, a researcher at the National Institutes of Health, found that even when meals are matched for calories, carbohydrates, protein, fat, sugar, salt and fiber, study participants who are instructed to eat freely will still, without realizing it, consume an average of 500 calories more a day if the food is ultraprocessed. “Any kid is going to choose an ultraprocessed food,” says Marion Nestle, an emerita professor of nutrition, food studies and public health at N.Y.U. and the author of “Food Politics.” Nestle traces the deregulation of food marketing to the Reagan presidency and the shareholder-value movement. “After 1980, kids were fair game,” she told me. Corporations began aggressively marketing their products to children, potential lifetime customers who are easily influenced. Ultraprocessed foods appeal to parents too: They’re cheap, last for years in pantries and freezers and require little preparation. “All food companies are trying to sell products,” Nestle says. “That’s the system, and if the system makes kids fat, well, too bad. Collateral damage.” In the United States, that damage is inflicted more harshly on some groups of children than others: The obesity epidemic disproportionately spares white and Asian children and those from socioeconomically advantaged families. Living in the highest-opportunity neighborhoods, especially at birth, could be associated with as much as an 80 percent lower risk of obesity. Among Black children, however, the protective effect of income against obesity seems to be weaker.Over the past few decades, the variety of food items in some supermarkets has risen to more than 40,000 from 7,000. These “modern industrial products should not be recognized as foods at all,” says David Ludwig, a pediatrics professor at Harvard and co-director of Boston Children’s Hospital’s obesity-prevention center. “It’s up to parents and all of us to fight back and not to normalize these.” The A.A.P. urges doctors to “demand more of our government” to modify the food being sold to children. But Barry Popkin, a nutrition professor at the University of North Carolina who has worked with countries on their food policies, remains skeptical that similar regulations could be enacted soon in the United States, like Colombia’s tax on ultraprocessed foods or Chile’s restrictions on them in schools and on advertising. “We need our F.D.A. to be bold,” Popkin says. “We need a food czar who’s tough, not these namby-pamby bureaucrats that don’t really want to ruffle any feathers.” At Texas Children’s Hospital, Alexandra lay asleep in the operating room, on a tilted bed, with her feet lower than her head. Gravity now worked to the surgeon’s advantage, pulling her intestines away from her stomach. Rodriguez, wearing a “Peanuts”-themed cap with his scrubs, made five half-inch incisions throughout her abdomen, while the music of Bruno Mars and Elton John softly played in the O.R. Rodriguez then inserted a camera and his tools through the cuts. Alexandra’s insides appeared on four surrounding screens.Rodriguez pulled back her liver, its edges rounded from fat, and pushed aside mounds of squishy yellow fat — findings that he sees only in his bariatric patients — to reveal her stomach, pink and patterned with red vessels like fine tree branches. The anesthesiologist had snaked a tube through Alexandra’s mouth into her stomach. Rodriguez could now follow the contour of the tube with a surgical device that sequentially cut, stapled and sutured stomach tissue. Next came what Rodriguez regarded as the hardest step, wrestling the excised portion of the organ, about 80 percent of the whole, out through one of the tiny incisions. To make sure that what remained of her stomach had been fully stitched up, the anesthesiologist pumped air through the tube into the organ, which now resembled a slim shirtsleeve — hence the procedure’s name, sleeve gastrectomy — and Rodriguez flushed water into her abdomen: Bubbles would indicate a leak somewhere. The water was still. The operation was completed in under an hour. Most of Alexandra’s stomach now sat on a tray, cool and dusky. Dr. Jose Ruben Rodriguez, center, during Alexandra’s surgery.From Texas Children’s HospitalIn another room, with children’s artwork adorning the bright aqua walls, Alexandra’s parents sat on orange chairs and waited, until Rodriguez came in and knelt next to them. “There’s no blood loss at all, which is nice,” he told them in Spanish. In the postoperative area, Alexandra, still confused from the anesthesia, writhed around. With every movement, she hurt. “It’s so hard to see her like this,” Gabriela said, as she smoothed her hand over her daughter’s forehead and begged her to lie still. Alexandra let out a moan.“When we first started, the hospital businesspeople told us there’s not enough surgeries to justify building a program,” Rodriguez told me. “Obviously, that’s not how things turned out. It’s the exact opposite.” The number of teenagers who underwent bariatric surgery more than doubled nationwide between 2010 and 2017 and continues to rise. According to Teen-LABS, which is funded by the National Institutes of Health and which has been conducting the most research on the procedure in the United States, adolescents who have had bariatric surgery — most of them white and female — experienced weight loss similar to what adults lost: around 25 percent of their B.M.I. And while nearly 90 percent of these teenagers needed diabetes medications before the operation, none did afterward; five years later, they were more likely to have their diabetes and hypertension in remission compared with people who had surgery as adults. “There’s a greater positive impact for operating on youth with these two conditions than waiting until adulthood,” says Thomas Inge, chair of surgery at Lurie Children’s Hospital, in Chicago, and the principal investigator of Teen-LABS. “You get more out of the same operation.” Even 10 years after the procedure, the data indicates that there are long-term benefits from surgery. Teenagers do not seem to experience more complications than adults.“Patients lose weight, and they’re less hungry while they’re doing it,” says Randy Seeley, a professor at the University of Michigan who researches the surgery’s effects on a molecular level. Seeley emphasizes that weight loss doesn’t simply result from a newly tiny stomach that limits how much people can eat. Many chemical changes are also responsible, some of which resemble what happens when people are on Ozempic, although these similarities are not thought to be the main mechanism behind surgery’s effectiveness. The crucial roles instead seem to be played by bile acids and antimicrobial peptides in the gut, each of which increase markedly after surgery; Seeley is still sorting out the exact mechanisms of their influence. Also, a majority of the stomach that secretes ghrelin, the hunger hormone, is removed in sleeve gastrectomies. “Why bariatric surgery works so well is because you’re changing lots of things at the same time,” Seeley says. Most important, bariatric surgery seems to reset, to a lower bound, the body weight that the brain tries to maintain. There is less of the persistent metabolic slowing that accompanies traditional weight loss. Based on fMRI scans, the response to food cues in the brain — around the hypothalamus and in the reward and cognitive-control regions — appears to be different in post-surgical patients than it is for those on low-calorie diets. But how altering the anatomy of the gut changes the brain is still a mysterious phenomenon — mostly “a black box,” Seeley says. And it still seems to surprise everyone, even those who perform the operation. “I’m just a basic gastrointestinal surgeon,” Inge says. “Never thought I’d get to claim to be a brain surgeon. But, hey, that’s where it seems like the impact is.”Only a tiny fraction of the teenagers with severe obesity who qualify actually receive the operation. The obstacles in front of them are hard to get past: finding a pediatric bariatric surgeon, navigating the long, arduous process of insurance authorization — assuming the procedure is even covered by the insurer. “We’ve seen all sorts of shenanigans for trying to not approve kids,” Inge says. Some parents, desperate to help their struggling children, feel they have no choice but to pursue treatment without insurance coverage. In 2021, after A’kaysha Studstill tried to take her own life by overdosing, she and her mother, Anastasia, traveled from Florida to Tijuana, Mexico, for bariatric surgery; the trip, including the sleeve gastrectomy, cost around $6,500. “People questioned me taking her out of the country,” Anastasia says. “But you don’t know what I’m dealing with. The bullying — she would shut down for days. She was going to kill herself.” This summer, A’kaysha told me she had lost a third of her weight. Wearing a crisscross black halter top, she beamed while packing up her room to start her freshman year at Florida State University. “There’s always more options than just giving up,” she said. “You don’t have to diet and starve yourself.”Several studies have shown an increased risk of suicide in adults after bariatric surgery. This association may not be a result of patients already at higher suicide risk, like A’kaysha, choosing to go through with the operation. Meg Zeller, a professor at Cincinnati Children’s Hospital who researches the relationship between mental health and pediatric bariatric surgery and has studied the Teen-LABS cohort, has not found this link, but she cautions that adolescent data is “just a different ballgame” compared with the abundance of long-term data generated by adult cases. Data from eight years out shows that alcohol-use disorder is higher after bariatric surgery, possibly because the operation causes alcohol to be metabolized more slowly. While feelings of stigma and body image can improve, Zeller told me that anxiety or depression may not subside to the extent that diabetes often does. All teenagers experience life changes and increased vulnerability, she explains. “We’re talking about intervening at a time in someone’s life when lots of challenges can exist that are unique to that age group.”The morning after her operation, Alexandra, her hair in pigtails, shuffled slowly around her hospital room. She steadily took tiny sips of water. “There’s no going back now,” she said. If our biology, ingrained by evolution, is no longer well engineered for our modern surroundings, can pharmaceuticals help redesign us? One medicine that Alexandra took, metformin, which reduces glucose, has a moderate benefit for teenagers like her who also have prediabetes and polycystic ovary syndrome. But the latest glucagon-like peptide-1 receptor agonists — as a group, commonly referred to as Ozempic — are the true game changers, a class of drugs that are making possible a degree of weight loss not seen before with medications. The pharmaceutical company Novo Nordisk manufactures GLP-1s for weight loss, one of which is semaglutide and sold under the brand name Wegovy. (Ozempic is the brand name for a lower-dose version of semaglutide that is prescribed to treat diabetes by increasing insulin but has become so popular in the last year for cosmetic weight loss that it has helped Novo Nordisk’s market value surpass the gross domestic product of Denmark, where the company is headquartered.) GLP-1s are the “new frontier of anti-obesity medications,” says Aaron Kelly, co-director of the University of Minnesota’s Center for Pediatric Obesity Medicine. In a 16-month study that appeared in December in The New England Journal of Medicine, co-authored by Kelly, adolescents lost 16 percent of their B.M.I. on semaglutide compared with the placebo group, which gained 0.6 percent. The treatment group also registered improved cholesterol and liver tests. (Both cohorts underwent lifestyle therapy.)Semaglutide, currently administered through weekly injections at home, suppresses appetite primarily by acting on GLP-1 receptors in the brain. It may also reduce cravings by modifying the brain’s pleasure pathways. Outside the brain, it slows down the transit of food through the gut, so the feeling of fullness lasts longer. “When you put those three things together — the appetite, the satiety and the suppression of cravings — all of a sudden, you get a medication that has pretty profound effects on reducing weight,” Kelly explains. “I think we’re entering a new phase of pediatric obesity medicine, where we’re going to continue to see increasingly effective and durable treatments.” Gage Robbins, 17, who has been going to Herring’s program since March, with Lasheba Lankston, a medical assistant. He was prescribed semaglutide, but his insurance doesn’t cover it.Kholood Eid for The New York TimesFor several years, Eriyanna Stovall, who just turned 14, has tried unsuccessfully to reduce her meal portions. Her attempts at more healthful eating were also thwarted by the temptation of junk food in the house that her younger siblings, who do not have obesity, love to eat. “I would crave junk food 24/7,” Eriyanna says. She snacked late at night on Doritos and strawberry shortcake in her bedroom. Her mother, who is a nurse, raised the A.A.P. guidelines with their pediatrician, but she doesn’t prescribe weight-loss medications. When I spoke with Eriyanna in May, she had been on Wegovy for a month, after the family found an obesity specialist. “At first, I was really scared because I don’t like shots,” she told me. “But it felt like a little instant pinch.” For the first two weeks, Eriyanna didn’t notice a change. Then her mother observed that she was full after finishing half her plate, instead of asking for her usual seconds. Since the surgery, fruits and vegetables “are tasty to me now,” Eriyanna says. “I think the medicine did something to my taste buds.”The major studies of children and these drugs have enrolled many fewer adolescent subjects than adults, but no new safety concerns have emerged. In addition to semaglutide’s principal side effects of nausea, vomiting and diarrhea — reported by two-thirds of study participants — more serious ones include gallstones and pancreatitis. Wegovy comes with a caution about possible thyroid cancer, and the F.D.A. mandates that it include a warning about the possibility of suicidal ideation, because it acts on the brain; further studies are being conducted in Europe. If patients discontinue the medicines, the weight returns. Compared with fen-phen, a popular weight-loss drug in the 1990s that was eventually linked to heart-valve problems, doctors are less concerned about semaglutide, because older drugs in its class have been used to treat diabetes for nearly two decades. But for any new medicine, the long-term risks remain uncertain. For now, most adolescents who qualify for semaglutide probably won’t be able to get the drug at all. “I always say it’s an insurance game,” Treah Haggerty, a family-medicine obesity doctor at West Virginia University Medicine, told me. “What hoops can you jump through?” If families pay out of pocket, monthly costs could reach $1,400. “We’re creating haves and have-nots,” Haggerty says. Even with insurance, parents may still encounter drug shortages; Novo Nordisk is already restricting the U.S. supply of starter doses into 2024, effectively limiting new patients. Eriyanna was forced to stop Wegovy when the drug became unavailable to her this summer. She switched to an older, less effective GLP-1, but then that went on back-order too. “We are so devastated,” her mother texted me recently. “It seems like a very big mountain we are climbing.”For every child given a diagnosis of being overweight or having obesity — even those who choose medication or surgery — the A.A.P. encourages immediately starting intensive health behavior and lifestyle treatment, like the one Alexandra undertook. For younger children, this may be the only therapy available to them. Amanda Staiano, a developmental psychologist who helped write the A.A.P. section on lifestyle programs, describes them as “trying to re-engineer the child’s environment and helping with positive parenting strategies.” This spring, Micheal and Christi Pientowski took their 5-year-old daughter, Emmie, to one such program in Madison, Miss., a state with one of the highest childhood-obesity rates in the country. They were referred by Emmie’s pediatrician because she was gaining weight rapidly; her B.M.I. was pulling upward away from her growth curve on the C.D.C.’s B.M.I. chart.At their first appointment, Emmie’s parents told the doctor, Whitney Herring, that they were worried about Emmie’s appetite. “She eats, then she’ll immediately be like, ‘Can I have a snack?’ or ‘When are we eating?’” Micheal said. “If we didn’t stop her, she would keep asking for more and more,” Christi added. “She would get mad at us for having more than she did.” “We wanted Emmie to see somebody before kindergarten,” Micheal says. “We know how kids are these days. We just don’t want her to be bullied.” Herring told them not to expect a fast fix. “Even with the body mass index coming down, that is often not a quick process,” she said. If kids see any reduction in B.M.I. from lifestyle treatment, the average is a 1 to 3 percent change in percentile, though other health indicators may improve. Herring asked about Emmie’s meals.“We’re working on it,” Christi said. “The only vegetable that she will eat is carrots.”“What about at school?” Herring asked. Christi described a lunch with green beans and peas. The doctor turned to Emmie, who is blond with ruddy cheeks and dimples. “Do you like those at school?” “No! I never eat those.” “Do you ever have broccoli at school?” “No!” “We are very picky, too,” Christi said. She avoided most vegetables herself. (Some families have trouble affording vegetables or lack the time to prepare them.)At school, children like Emmie may not touch their lunch, or they might snack from vending machines. But improving school meals involves more than just substituting asparagus for fries. Judith Siebart, a dietitian who worked with schools nationally, recalls being told, “We can serve all these healthy foods, but if the kids don’t eat it, what have we gained?” Next, Rebecca Bagwell, the program’s dietitian, wheeled in a cart stacked with silicone foods. She pulled out a seven-inch plate sectioned into different proportions for various foods groups, following MyPlate suggestions. Emmie chose what she liked — chicken, mac and cheese — as Bagwell piled them on the plate in generous portions. “So do you feel like you would want more or less than this?” Bagwell asked.Emmie looked at the plate. “More?”Some of Herring’s patients have trouble getting exercise. One boy, who told me the farthest he has walked is down his block, signed up for track team. But the school never started practice. His experience is not uncommon among poorer youth, whose sports participation rates are lower. And while two-thirds of ninth graders attended physical education weekly in 1991, only one-third did so in 2019. Though exercise alone may not result in profound weight loss, it has extraordinary health benefits — and helps our brains regulate appetite.Drew Keith, 13, has been a patient of Herring’s since June. He has lost 21 pounds through lifestyle changes.Kholood Eid for The New York TimesHerring has expanded her program to cover three different parts of the state, but she still expects as much as 30 percent of her appointments to be no-shows — a problem for many lifestyle treatment programs. From parents missing work to children missing school, families have trouble going to them — if they can find one at all. Herring reckons that the A.A.P.’s recommendation that patients attend at least 26 hours in person over three to 12 months is not feasible for most: “I have yet to find even the most motivated person who’s willing to do two visits a month.”Many primary-care doctors do not have a program like Herring’s to refer their patients to. “It puts more pressure on me to make sure that I’m not only identifying these kids,” says Sarah Hart, a pediatrician in Kentucky, “but in the short time that I do have with them, how can I really home in and find those areas that we can make a real sustainable change?” It can seem like an impossible ambition to achieve in 15-minute primary-care appointments.How the medical community approaches patients’ weight — and whether it should even be diagnosing or treating obesity — has led to all sorts of criticism, which has been growing ever since the American Medical Association declared in 2013 that obesity is a disease. While some people felt relief in knowing that they had a medical disorder, many others felt injury in being considered diseased. As weight became a preoccupation in doctors’ offices and the size of people’s bodies became subject to medical treatment — even if they seemed otherwise healthy — patients felt increasingly more stigmatized and concerned that the care they received was biased. Remedies that were meant to help with obesity instead seemed to be hurting the people with the condition. One of the most vehement responses to the A.A.P. guidelines came from the Collaborative of Eating Disorders Organizations. “This idea of weight loss for higher-weight children — I think all of us were just completely taken aback,” says Johanna Kandel, chief executive of the National Alliance for Eating Disorders, who helped spearhead an open letter from CEDO that responded to the guidelines. Calling them “harmful” and “irresponsible,” the letter’s foremost concern was that screening and treating children for obesity can lead to eating disorders, for which youth at higher weights are already at increased risk. Tracy Richmond, who directs the Boston Children’s eating-disorder program, explains that weight loss in children can trigger eating disorders by making them “hyperfixated on weight and body,” which can then “spiral out of control.” As children continue to restrict their intake, they can become “undernourished relative to where their body would like to be,” a type of anorexia, even if their B.M.I. may not have fallen into the low range. Other eating disorders — bulimia, binge eating — also may emerge.CEDO’s open letter registered its unequivocal opposition to treating children with obesity with drugs or surgery on the grounds that the long-term effects of these procedures on pediatric patients haven’t been well studied and could also worsen disordered eating. But criticism was also directed at pushing children to make lifestyle changes — what the journalist Virginia Sole-Smith calls “textbook diet culture marketing” in her 2023 book, “Fat Talk” — because these can also eventually lead to eating disorders. (Sole-Smith has written for this magazine.) While research has shown that intensive treatments focusing on health and lifestyle behaviors decrease eating disorders, some experts have pointed out that those studies don’t track children long enough to know if they end up developing disorders; most of this research followed the children for only a year or less. Such concerns raised by CEDO are particularly worrisome, given that the rate of eating disorders doubled in teenage girls during the pandemic.Focusing on weight in medical settings can also worsen the care children receive. Two-thirds of people with obesity report experiencing bias from doctors. In extreme cases, this can result in devastating consequences, including missed or delayed diagnoses — even death. The health care system may blame parents for their children’s weight and accuse them of overfeeding or not providing enough healthful food. A few states have even moved children with severe obesity into foster care.Takira Edwards, 18, has diabetes, high blood pressure and polycystic ovary syndrome. In July, Herring referred her for evaluation for bariatric surgery. She has an appointment in November.Kholood Eid for The New York TimesThe pushback against conceiving weight as medical problem has brought intense scrutiny to the act of measuring obesity. The backlash against B.M.I. — calculated as weight in kilograms divided by height in meters squared — has been especially forceful. B.M.I. doesn’t take into account whether the weight comes from muscle or fat or where in the body it’s distributed. In June, the A.M.A. began to move away from the measurement when it acknowledged that “B.M.I. cutoffs are based primarily on data collected from previous generations of non-Hispanic white populations and does not consider a person’s gender or ethnicity.” For now, the A.A.P. still endorses B.M.I., in part because alternative measurements can’t readily be performed in most pediatricians’ offices.Diagnosing people whose B.M.I.s exceed a certain level with obesity — a disease — can increase weight stigma outside medical settings as well. “Our entire concept of ‘fat is bad’ is so rooted in anti-Blackness, white supremacy,” Sole-Smith writes. “When we strive for thinness, we’re reinforcing every other form of stigma at the same time.” People in larger bodies may be perceived as “lazy,” “stupid” or “sloppy” and are constantly vulnerable to insults, slights and jokes. Stigma can also be surprisingly insidious. “If parents say, ‘Fruits and veggies are awesome because it helps us lose weight,’ the weight stigma starts to creep in,” says A. Janet Tomiyama, a psychology professor at U.C.L.A. Experiencing stigma or discrimination because of body size can worsen or even cause health problems.When it comes to individuals, it’s undeniable that people with obesity can be metabolically healthy, just as normal-weight individuals can be unhealthy. Some studies have even shown that normal-weight individuals may not live as long as those with higher B.M.I.s. Findings like these, along with a greater awareness of the drawbacks that can accompany the medicalizing of obesity, have fueled popular body-positivity movements like Health at Every Size, which seek to disentangle weight from health. But despite the risks that can accompany obesity treatments — and despite the fact that the data doesn’t always present a clear picture — the prevailing attitude within the medical establishment is that, on balance, the potential negative consequences of obesity are too evident to ignore. When Andrew Stokes, a demographer and public-health professor at Boston University, used people’s weight histories and adequately accounted for important factors like smoking and illnesses, he found that obesity was associated with significantly shorter life spans. Studies can’t prophesy what will happen to any one person, he says, but “this is about probabilities and relative risks.” He adds that obesity is “a cumulative process.” Children with obesity may not be dying of heart attacks, but the Bogalusa Heart Study — one of the longest-running epidemiological studies, it recruited children in the 1970s and followed them through middle age — has nonetheless found that childhood obesity is already associated with cardiovascular and kidney changes that then developed into diseases in adulthood. These findings have been confirmed by autopsies of youth who died in accidents. During the pandemic, obesity was the most common medical condition associated with deaths of people under 21. Lila Monahan, a primary-care pediatrician who uses B.M.I. as a screening tool to help prevent diseases, asks why you would wait until someone started developing abnormalities. She says that’s “like saying someone has high blood pressure, but they’re not having heart attacks, so why are we even measuring their blood pressure?” Ariya Thompson, 6, had been gaining excess weight, but she wasn’t referred to Herring until she was found to have abnormalities on her blood work, including one concerning for prediabetes.Kholood Eid for The New York TimesThough the A.A.P. guidelines include advice on how to minimize weight bias and avoid stigmatizing patients, and even though they recommend screening children with obesity for eating disorders — and were even vetted by eating-disorder experts, Hampl told me — such safeguards may not be enough. The potential harm that the CEDO letter warns about became a reality a few years ago for a fifth-grader whose middle name is Esther. Her school in New Jersey sent home a letter to be signed, a “B.M.I. report card,” that said her B.M.I. was greater than the 95th percentile for her age. The signature that was required was not her parents’ but her doctor’s. The pediatrician told her mother, Lynn (also a middle name), that the weight gain “was not a big deal” and mentioned an academic medical center’s program that “you guys may want to look into.” The first session taught Esther to assign traffic lights to foods: vegetables, green; candy, red. “They weren’t like, ‘Oh you’re too heavy,’” Lynn says, “It was more like, ‘This is a way to be healthier and change your lifestyle so you can keep this as part of your routine for the rest of your life.’” Esther seemed uncomfortable, though, and cried in the car afterward. “The whole family can do better to eat healthy,” Lynn reassured her.Esther refused to go back. But that summer, she told her parents she was trying to be “healthier.” She started eating less and walking to school. Then her weight began to drop. The following spring, Esther was diagnosed with anorexia. Over all, she needed four hospitalizations and five months in a residential treatment facility across the country during the pandemic. There, she kicked so hard to resist a feeding tube that she nearly broke Lynn’s ribs. Later, Esther’s heart rate plunged dangerously. “We almost lost her,” Lynn says, her voice cracking. Esther is better now, but her family remains unsettled. The pandemic’s social isolation was central to her daughter’s eating disorder, Lynn says, but the lifestyle program “was probably the catalyst for it.”“I’m feeling more confident in myself — like, I’m no longer wanting to hide away in a jacket or hoodie,” Alexandra told me in October. Four months after her surgery, she has lost more than 50 pounds and is thrilled to feel good wearing a dress for the first time in a long time, for homecoming. “I’m so proud of her,” Alexandra’s mother says. “She’s doing so great.” Alexandra’s improved health means she has been able to stop taking her diabetes pills. She will, like all patients who receive bariatric surgery, have to take vitamins for the rest of her life, in part because her altered gastrointestinal tract does not absorb nutrients as well. A decision she made at 16 will continue to affect her entire life. For someone like Fatima Cody Stanford, a specialist at Harvard who cares for both children and adults with obesity, that’s a positive thing: Redirecting Alexandra’s health in this way is how clinicians should approach childhood obesity. Stanford, who has been using many of the therapies in the A.A.P. guidelines for over a decade, sometimes sees her pediatric patients or their families defer more aggressive treatment, then grow up into adults with obesity, which may pose even greater dangers to their health and be harder to treat — a progression Stanford would like to interrupt when people are still young. “Many people still have this really strong intrinsic belief that if it’s not diet and exercise, then you must have just failed as a human being, particularly in the pediatric population,” she says. As increasingly more effective remedies become available to children like Alexandra, more of them might be set up to lead longer, healthier lives — the reason the A.A.P. put out such comprehensive and urgent guidelines. Yet they are also the same children that others fear will be deeply harmed the most by these very recommendations, and in ways that they may not grasp at such a young age.Alexandra still exercises most days, but it’s tough to balance a routine with a demanding junior year — two A.P. classes, SAT prep, competing for a summer language program in South Korea. After her operation, dining out with her family has become less enjoyable. She feels full so easily now; even when meals taste delicious and she wants to eat more, she can’t, because she is no longer hungry. Sugar also makes her feel nauseated, so she avoids sweets even though she really wants them sometimes. But, Alexandra says, she was so disheartened before the surgery, putting so much effort into losing weight and feeling like she was “accomplishing nothing.” Now, she says, “it’s refreshing to see the hard work I’m putting in is finally showing results.”Helen Ouyang is a physician and associate professor at Columbia University and a contributing writer for the magazine. Her writing has been a finalist for the National Magazine Award and anthologized in “The Best American Science and Nature Writing.” Kholood Eid is a Palestinian American photographer, filmmaker and educator based in New York. She was part of the team at The Times that won a 2020 Robert F. Kennedy Journalism Award for a series investigating online child sexual abuse.

Read more →

The Hospital Makes a House Call

Listen to This ArticleAudio Recording by AudmTo hear more audio stories from publications like The New York Times, download Audm for iPhone or Android.Manuelita Romero sipped cranberry juice as she lay in her bed, surrounded by pillows, blanketed under a soft white cover patterned with blue-and-green flowers. She was 92 and wearing pearl earrings and a necklace of rosary beads. Her bedroom, in a sandy, one-story adobe-style house in southwestern Albuquerque that she shared with one of her sons, was decorated with figures of saints and angels, along with more than a dozen crosses. Perfume bottles, hair spray and tubes of lotion crowded the top of her gold-trimmed cream dresser. Her house was very small but cheery and cozy, with crochet, flannel and serape coverings on the furniture and bright lemon-yellow cabinets in the kitchen.Tucked in the back corner of her ordinary-seeming bedroom was a tall, slim metal pole. From its top hung a translucent bag, apparently empty; a thin clear tube dangled from its bottom. Hidden behind the bed was a small canister. A week earlier, Romero caught a drug-resistant urinary-tract infection that needed to be treated intravenously with a strong antibiotic. At the same time, she experienced a flare-up of her congestive heart failure: Her legs swelled enormously — a result of fluid backing up in her body — and she struggled to breathe. As she became weaker and more confused, her doctor, Elizabeth De Pirro, knew that she needed to be hospitalized.But in this case, hospitalization had not required Romero to leave her house. De Pirro is the medical director of Presbyterian Healthcare Services’ Hospital at Home program, which has been providing people with acute inpatient-level care in their own homes since 2008, one of the oldest such programs in the country. Earlier that morning, a nurse stopped by Romero’s home to dispense a dose of antibiotics via IV drip from the metal pole. The medicine bag had been stored in the kitchen refrigerator. A cannula supplied oxygen from the canister to Romero’s nose. There were no devices present to measure the activity of her heart and lungs; there were no needles, or even a shred of gauze. The nurse had brought the equipment with her and packed it up and taken it away when she left.De Pirro, who is 62 and has short, dark curly hair, olive skin and deep brown eyes, pulled up to Romero’s home in her dark gray Toyota 4Runner, then propped up a screen under the windshield to fend off the brutal New Mexico summer sun. Romero’s son, Victor, opened the door to the house and welcomed the doctor inside. After a quick greeting, De Pirro, wearing a hospital badge clipped to her collar but no white coat, began whipping out medical equipment from her backpack. She deftly maneuvered a blood-pressure cuff onto a part of Romero’s arm that she knew wouldn’t bother her and attached the pulse oximeter to her finger, then entered the vital signs into her laptop. She listened to Romero’s lungs and touched her ankles — they were less swollen today. The therapy was working, De Pirro told her. Then she called up Romero’s lab results on her laptop and showed them to Victor, pointing out that her numbers were improving. He nodded enthusiastically while explaining that he knew she was getting better even before he saw this data. He was eager to get her out of bed tomorrow.After completing her examination of Romero, the first of her rounds that morning, De Pirro had a 30-minute drive ahead of her. On many days, she logs more than 100 miles around Albuquerque. She equips her car with her toothbrush, floss picks and eyeglasses in its center console. Her cupholder brims with a dozen pens. When De Pirro scrolls through her patients’ electronic medical records, she doesn’t just gather their clinical data; she also takes note of their home addresses and maps the most convenient routes between them.De Pirro in Walker’s home. Walker, who is 52 and in remission from a blood cancer, went to the emergency room and was diagnosed with pneumonia. Preferring to be at home with his wife and three children, he received oxygen therapy and five days of intravenous antibiotics through Presbyterian Healthcare Services’ Hospital at Home program.Kholood Eid for The New York TimesDuring her drive, De Pirro fielded calls over her car’s speakerphone from team members at patients’ homes: A nurse practitioner wanted help prescribing a pain reliever; a pharmacist was trying to sort through someone’s insulin regimen. Eventually De Pirro pulled up to a white trailer with green trim. Three barking dogs rushed toward her. De Pirro glided around them, patting their heads while strolling up to a tall thin man with long, dirty-blond hair and an empty holster on the right hip of his bluejeans. Bob Saltzman, who is now 59, preferred to sit outside during these hospital visits. While checking his vital signs, De Pirro asked him about his daily fluid intake. “I never drink water,” Saltzman said. “I like Pepsis.”“Pepsi is not a very good way to hydrate for your kidneys,” she said. “So, get some Gatorade. A little more fluid, you’ll feel even better.”De Pirro plopped her computer on top of a barbecue grill, and as Saltzman talked, she typed, while also reviewing his blood tests. A few days earlier, he had been doing yardwork when he became dehydrated and overheated, then fainted. He was rushed to the emergency room, whirled through a flurry of tests and then hospitalized through De Pirro’s program in his trailer home. After three days of treatment, his kidney function, which had been impaired by the episode, seemed to have mostly recovered. She planned to discharge him the next day, she told him.Later that afternoon, Erica Guardiola, a nurse wearing scrubs and her hair in a ponytail, stopped by Saltzman’s trailer to draw his blood and dispense another liter of IV fluid. Inside his tiny, cramped dwelling, a gun rested on his dresser, next to a coffee maker; a box of bullets sat on his bedside table, with a jumbo jar of peanut butter underneath. De Pirro was practical about situations like this. “This is New Mexico — a lot of people have guns,” she told me earlier. “We can’t tell people they can’t have guns,” though she added that they’re not supposed to be out in the open when medical workers visit. De Pirro is not cavalier about her staff’s safety, but she says firmly that in all her years of providing hospital-at-home services, she has “never had a problem — and we go into all kinds of neighborhoods.”Strewn around Saltzman’s room were a 24-pack of Pepsi, a bag of pecans and a fantasy novel; Twizzlers wrappers filled the garbage can. What did you eat today, Guardiola asked, while she applied a tourniquet on his right arm in preparation for his blood draw. Oatmeal, he answered.“Oatmeal is good, but you do need to eat a little bit more protein and food throughout the day to get the nutrition in your body,” Guardiola said. She suggested that he eat more of his peanut butter, starting that evening. Saltzman nodded. She offered to get him some meal-planning booklets. A small light brown dog had nestled into a pile of his sweats. “She’s always with me,” he said with a grin.Oxygen equipment for Roberta Thornton, another patient with pneumonia. De Pirro calls Thornton, who is 69, the “perfect candidate” for hospital-at-home because she is very active and cares for her young grandson.Kholood Eid for The New York TimesGuardiola prefers to care for her patients in this intimate way — by seeing how they live and being able to offer relevant advice, not just injecting them with medicines. “In the hospital, you’re like hustle and bustle, moving from room to room,” she says. “But here, we get to go into all different walks of life all over town and do a whole lot.” Now, because of a serendipitous — or mercenary, depending on one’s perspective — hand dealt by the pandemic, hospital-at-home services may soon be available to millions of Americans. Instead of being hospitalized, patients might be able to stay home, while doctors, nurses and other medical workers come to them, sometimes in person, sometimes virtually. “You see patients in their place of power, it’s a totally different thing,” De Pirro says. “That magical difference.”More on the Coronavirus PandemicLong Covid: An analysis of workers’ compensation claims in New York found that 71 percent of claimants with long Covid needed continuing medical treatment or were unable to work for six months or more.Annual Boosters: The Food and Drug Administration proposed that most Americans be offered a single dose of a Covid vaccine each fall, much as they are given flu shots.A Better Covid Winter: Some of the worst days of Covid in the United States have come as winters have settled in. But a surge in hospitalizations has yet to materialize this season.New Subvariant: A highly contagious version of the Omicron variant — known officially as XBB.1.5 or by its subvariant nickname, Kraken — is quickly spreading in the United States.The American health system needs more hospital beds. This reality became terrifyingly palpable during the pandemic’s worst surges, when I.C.U.s and other wards were forced to turn sick people away. In urban emergency rooms, admitted patients frequently languish for hours, sometimes even days, and occasionally in hallways, before they are moved onto inpatient floors. The situation can be more dire in rural areas; some communities may soon be left without any hospitals at all. In 2020, 19 rural hospitals were shuttered, more than in any year during the previous decade. Nearly 30 percent of all rural hospitals are at risk of closing, especially tiny, stand-alone facilities. These circumstances are likely to get worse as the baby-boomer generation continues to age, in part because of the staggering expense of hospital construction: A new 500-bed hospital can cost more than $2 billion in some cities. Health care in the United States is already more expensive than anywhere else in the world.Hospitals aren’t even the ideal places to heal, oftentimes. Infections spread among patients, occasionally with fatal results. The constant alarms and beeps made by all the monitors and machinery interrupt sleep and recovery. Older patients in particular become agitated and confused by the disruptions. Some patients have to go through rehabilitation afterward, having been confined to a hospital bed for so long. It’s no wonder that both patients and clinicians alike might want an alternative to traditional hospital care.Presbyterian started its home-hospital after a 2005 paper in The Annals of Internal Medicine found its way to its executives’ desks. The lead author, Bruce Leff, a geriatrician and professor at Johns Hopkins School of Medicine, successfully conducted a pilot trial in the late 1990s. (I met Leff later, when I was a medical student there.) With support from the John A. Hartford Foundation and the hospital leadership at Hopkins, Leff hospitalized patients in their own homes who were at least 65 and had been given one of a few straightforward diagnoses: a worsening of their heart failure, or emphysema, pneumonia or a bad skin infection. These patients did so well that Leff tried to spread the word by calling hospital leaders. “You kind of got the sense that people thought I had two heads,” Leff told me.Eventually he persuaded a few institutions, including a Department of Veterans Affairs medical center, to take part in a trial. The researchers found that patients treated in their homes had shorter stays of hospitalization and that their care cost about 30 percent less. Because Presbyterian, like the V.A., runs its own health plan, which covers the cost of some patients’ medical services, it has more flexibility than many other hospital systems. With Leff advising, Presbyterian was able to open hospital-at-home for patients insured through its plan.Other countries, including Australia, Canada and several in Europe, had already been experimenting with this practice, some of them extensively. In Australia, which has been running home-hospitals for decades, these services provided in Victoria alone are the equivalent of what a 500-bed facility could offer in one year. Overall, the patients treated in this way do just as well, if not better, in their homes.De Pirro arriving at the home of Francis Rath, an 86-year-old with a serious leg infection.Kholood Eid for The New York TimesThe obstacles impeding Leff and other hospital-at-home advocates in the United States were bound up with America’s labyrinthine health care system and particular medical culture. The Centers for Medicare and Medicaid Services (C.M.S.), which is the largest payer of hospitalizations, has required that nurses must be on site 24 hours a day, seven days a week, effectively keeping patients within the hospital walls. This matches how American society has come to regard hospitalization, too — nurses at the bedside, doctors making their rounds, in elaborate facilities pulsating with machines.But Americans didn’t always convalesce in hospitals. Before the 20th century, treatment at home was the norm. “Only the most crowded and filthy dwellings were inferior to the hospital’s impersonal ward,” the historian Charles E. Rosenberg writes in his 1987 book “The Care of Strangers: The Rise of America’s Hospital System.” “Ordinarily, home atmosphere and the nursing of family members provided the ideal conditions for restoring health.” As Rosenberg puts it, “Much of household medicine was, in fact, identical with hospital treatment.” As health care became more specialized and high-tech, however, diagnosis and treatment gradually moved into hospitals, and they evolved into institutions of science and technology.More than five years after Presbyterian began offering its services, C.M.S.’s Innovation Center funded a $9.6 million, three-year study that enabled Mount Sinai to take its hospital into the Manhattan homes of its patients who were covered by traditional Medicare. These patients suffered from a broader mix of illnesses — including hyperglycemia, blood clots and dehydration — than those in Leff’s original study. Albert Siu and Linda DeCherrie, geriatricians at Mount Sinai and two of the trial’s leaders, bundled the hospitalization care with one month of post-discharge assistance. They ensured that patients got to their appointments, filled their prescriptions, underwent physical therapy if needed — the sort of follow-up services that patients sometimes forget or neglect after they leave the hospital.The study, to which Leff contributed, showed that patients hospitalized at home were discharged two days sooner, with lower rates of E.R. visits and hospital readmissions, and that they were less likely to need rehabilitation afterward. They also gave their care higher ratings. Though C.M.S. recognized hospital-at-home as a worthy model, the agency didn’t endorse it because it didn’t immediately save billions of dollars, according to Harold Miller, the president and chief executive of the Center for Healthcare Quality and Payment Reform, who led the federal advisory subcommittee that evaluated the initiative. “We have the same old system we always have, and we didn’t do anything that actually would have been desirable to do,” Miller told me with regret. After the funding ended, Mount Sinai’s program had to find a way to get more payments to sustain its services. At Hopkins, hospital-at-home was simply discontinued after the completion of Leff’s 16-month pilot study.But Leff, Siu and DeCherrie continued to push the idea. They partnered with David Levine, an internist at Harvard Medical School who started Brigham and Women’s home-hospital program in Boston in 2016. Together, the four doctors created the Hospital at Home Users Group, to share lessons learned, hold webinars and organize conferences for health systems that were interested in their own initiatives. The intent was to spread hospital-at-home nationally, with the hope that it might eventually become a significant part of the American health care system.The first steps in this direction had already been taken, with the proliferation of ambulatory surgery centers in the United States over the previous 50 years. These facilities showed that patients didn’t have to stay in a hospital overnight, after all, following cataract surgery or a knee operation; they could recover in their own beds. Surgery there costs less than in hospitals, and as C.M.S. accepted more operations on its outpatient list, more centers opened. Recently, another important factor emerged: the spread of telehealth during the pandemic, which brought doctors into people’s living rooms.But the biggest catalyst has been the pandemic’s brutal impact on hospitals. As Covid hospitalizations first swelled across the country, threatening to overwhelm hospitals, C.M.S. was forced to respond. In March 2020, it announced that medical facilities could move hospital-level care into clinics and ambulatory surgery centers, and even into hotels and dorms. That November, it went further, creating the Acute Hospital Care at Home waiver, temporarily allowing hospitals to treat patients in their own residences. “It was a quick decision based on: We need to take action. We need to put solutions on the table. The health care system can’t wait, so let’s try this,” Seema Verma, the top C.M.S. administrator at the time, told me. “In absence of that, what were they going to do, right?”In a matter of weeks, C.M.S. was able, with the help of experts, including some members of the Users Group, to come up with a waiver that reimbursed health systems as much for inpatient-level care in the home as in the hospital, even though room and board wasn’t being provided. Nurses no longer had to be on site around the clock — only a minimum of two daily in-person visits by a nurse or a paramedic with additional training were required. Verma recalls no pushback. A handful of hospitals received the C.M.S. waiver immediately, including Presbyterian, Mount Sinai and Brigham.De Pirro with Sara Marquez, a registered nurse, in Rath’s home. After De Pirro inspected the infection with the dressing removed, Marquez dispensed IV antibiotics and went through a multistep wound-care regimen.Kholood Eid for The New York TimesSuddenly, Leff’s phone was ringing off the hook with calls from hospital executives seeking advice. The Users Group helped some of them navigate the waiver-application process. Today more than 110 health systems, amounting to some 260 hospitals — or about 5 percent of the country’s total — have obtained the waiver. (Geographically, the spread of home-hospital has been uneven; fewer than 10 rural hospitals have been approved so far.)The pandemic conditions that propelled hospital-at-home programs in the United States may now be waning, but the movement itself is maintaining its momentum. According to the consulting firm McKinsey, up to $265 billion worth of care annually being delivered in health facilities for Medicare beneficiaries — a quarter of its total cost — could be relocated to homes by 2025. A recent report from Chartis, another consulting group, finds that nearly 40 percent of surveyed health executives intend to have implemented a hospital-at-home program in the next five years; only 10 percent or so of the respondents do not expect to develop any plan at all. When President Biden signed the $1.7 trillion omnibus spending bill at the end of December, the C.M.S. waiver became extended through 2024. Currently, no official rules limit what cases can be treated at home, so long as the care meets the same standard as inpatient care in the hospital wards, but the spending bill tasks the federal government with figuring out who should be hospitalized at home. In Leff’s vision, that could mean almost everyone eventually, improbable as that seems now. He imagines that one day hospitals will consist only of E.R.s, I.C.U.s and specialized operating rooms.“When hospitals build a new building, they don’t do it themselves,” Pippa Shulman, the chief medical officer of Medically Home, told me. “We are the partner when you build a home-hospital.” Medically Home, a private company that started in 2016, has contracts with about 20 organizations, many of them signed during the pandemic. The firm choreographs the movements of local staff and suppliers, so that tests and visits can be carried out in people’s homes; if patients become too ill, they can be easily transported back to the hospital. Medically Home has created a technology platform to coordinate every step, so that — if everything is working right — a doctor will be able to make a computer entry and thereby prompt an action in the patient’s home as if it were being performed inside the hospital.An increasing number of companies like Medically Home have moved into the home-hospital business, among them Contessa, DispatchHealth and Sena Health. Some firms provide only technology, like video calls or remote monitoring. Others not only set up a hospital’s operations but also manage insurance contracts; Mount Sinai needed reimbursements after its federal grant ran out, so it partnered with Contessa to deal with insurers. (DeCherrie, one of the doctors who led Mount Sinai’s original trial, has since gone to work at Medically Home; Leff advises some of these companies.) Consulting firms are selling their expertise to health executives. Even private insurers are becoming more involved, not only to reimburse hospitals for the care at home but also to provide the services themselves, sometimes by working with start-ups to remove the hospital from the equation. Their clinicians meet patients in their homes before they ever step foot in the E.R., as De Pirro did for Manuelita Romero.In April 2020, Medically Home’s first hospital client, Kaiser Permanente Northwest — which, like Presbyterian, runs its own insurance plan — opened its hospital-at-home program. Because Oregon allows community paramedics to give in-home care, Kaiser Permanente is able to treat patients in that state using Medically Home’s nurses who are working out of a virtual command center in Massachusetts. During a typical day, these patients can expect video calls with their doctor and nurse and in-person visits from a medic, who checks their vital signs and gives medication. Ultrasounds, X-rays, even echocardiograms can be done in the home. For certain problems, like wound care, nurse practitioners might trek out to a house. The nursing and doctoring remain mostly virtual, however, unlike the treatment given through Presbyterian; a Kaiser Permanente patient might be hospitalized in his home in Longview, Wash., while his doctor is in Portland and his nurse is in Boston.In this way, Kaiser Permanente has served more than 2,000 patients in Washington and Oregon; nearly 500 more have been treated in its California program, which began in late 2020. To put these numbers in perspective, Presbyterian’s hospital-at-home has cared for fewer than 1,600 patients since its debut 15 years ago. Kaiser Permanente needs to operate on a scale like this, according to its executives, to offset the substantial investment that went into starting its hospital-at-home program. “There is cost to getting these programs off the ground,” says Mary Giswold, the chief operating officer of Kaiser Permanente Northwest. To cover them, Giswold explains, hospitals need to reach certain economies of scale. This may be another reason C.M.S. didn’t support hospital-at-home after the Mount Sinai study: To make financial sense, a hospital probably needs to treat at least 200 patients at home annually — a struggle for many places to reach at the time.Making hospital-at-home cost-effective for health systems comes with a different kind of cost, though. A patient may never feel the warmth of her nurse’s hand on her forehead, the reassurance of her doctor’s stethoscope over her heart. During a video visit that I sat in on, involving Kaiser Permanente’s program, the only glimpse I caught of the patient’s home was a bottle of Tums and a mug on her side table — a far cry from what De Pirro is able to see on her rounds. When the patient noted some lower abdominal pain, the doctor couldn’t reach through the screen to examine her; instead, he had to rely on a medic’s report. Arsheeya Mashaw, the medical director of Kaiser Permanente at Home for the Northwest, recognizes the trade-offs. “Although I’m sacrificing that bedside interaction with the patient,” Mashaw told me, “I’m also increasing the amount of patients I can see a day to provide that better care in home to the patient, which kind of makes up for the losses.”Critics fear that hospital-at-home may exclude those who are already marginalized — or, at the other extreme, become the only option available to those who can’t pay for their care. Both outcomes have the potential to worsen health disparities. “We would never not take somebody on because of the living conditions,” De Pirro told me, unless those were dangerous — a broken heater in winter, signs of domestic violence. At Mount Sinai, patients in public housing were not only accepted into its trial; the staff took steps to address some of their other needs, like finding ways to help them afford groceries or setting up transportation services, which might otherwise have been overlooked had the patients been in a hospital room. So far, Kaiser Permanente’s program has served a broad socioeconomic range. The recently passed federal spending package pledges to study the demographics of the people receiving this care.De Pirro visiting with Rath. When not elevating his leg, he used his walker several times a day to go to the bathroom and eat in the kitchen. “In the hospital,” De Pirro says, “he would have just been in bed and gotten completely debilitated and would’ve likely ended up in inpatient rehab.”Kholood Eid for The New York TimesInstitutions also need to figure out how best to deliver these services to them. Today the care varies widely, from Presbyterian’s in-person visits to Kaiser Permanente’s mostly virtual model. One program might send staff to check vital signs twice a day. Another might provide round-the-clock remote monitoring through wearable technology, which worries some doctors. “If a patient makes you nervous, and you think you want any kind of telemetry” — the continuous measurement of heart rate and rhythm — “they shouldn’t be home,” De Pirro says. “Because the reality is if something goes wrong, what do you need to do? By the time you get them anywhere, you’re talking 20 minutes realistically.”Some health workers cast a much harsher light on hospital-at-home’s unknowns. “How do we learn that a program about somebody’s life and health isn’t working? That means people were injured, or people died?” asks Michelle Mahon, the assistant director of nursing practice at National Nurses United, the largest nursing union in the United States. It strongly opposes hospital-at-home, referring to it as the “home all alone” scheme and claiming that, in the words of the union’s president, “nurses and other health professionals cannot be replaced by iPads, monitors and a camera.”In the union’s view, the health care industry is seeking to exploit the pandemic for financial gain by trimming away in-person care through hospital-at-home. Hospital executives should improve working conditions and increase nurse-to-patient ratios, Mahon says, not shift care to people’s homes. “The answer isn’t to send in less-skilled workers, who happen to also cost less,” she says, referring to community paramedics. (A nurse’s salary can be double what a medic earns.) Medics do not care for patients on the wards, Mahon says, so they shouldn’t do so in the home, either.While the underlying cost of caring for patients in their own homes may be cheaper, the path to profit is not swift or straightforward. Health systems, especially those that are also insurers, may eventually see sizable revenue from providing care at home. But currently, “it’s not as if it’s a cash cow and hospital systems are making tons of money,” says Amol Navathe, a health-policy professor and internist at the University of Pennsylvania, where he is co-director of the Perelman School of Medicine’s Healthcare Transformation Institute. That’s because of the significant upfront investment and the likelihood that reimbursement rates will go down. Instead, Navathe says, “hospital adoption of hospital-at-home is playing defense, in a sense” — against shifting rules for reimbursement, evolving expectations among patients and start-ups that encourage people to bypass hospitals’ front doors altogether.“The model is feasible, the potential is astronomical,” Navathe says, but how it fits into the American health care system is still “in the early days.” He warns in particular that single-payer countries’ successes may not be replicated in the United States, which tends to be “much more complicated and uses a variety of different fragmented stakeholders.” And he adds that he is skeptical that what is meant by hospital-at-home in the United States is the same as what is meant in other countries. In Australia, for example, iron infusions could qualify, but patients would not be hospitalized for those treatments in the United States. Even successful U.S.-based trials may not translate into real-world applications. Though the home-hospital patients in Mount Sinai’s trial did better than the inpatient subjects, they also had 30 days of aftercare that their counterparts did not get. And self-selection is a part of these studies; patients who go home choose to go home.Still, the health systems that have already put money into this are not likely to abandon their investments any time soon. Kaiser Permanente and the Mayo Clinic jointly made an initial investment of $100 million in Medically Home; the three organizations have also started a coalition to advocate making the C.M.S. waiver permanent. As part of a state-mandated performance-improvement plan, Mass General Brigham is counting on an annualized savings of $1.3 million to come from its home-hospital expansion. It may just be that the biggest doubt about hospital-at-home is not its survival but whether it can preserve its identity as it is amalgamated into the American health care system.“One of the things that I fret about as we try to hold hospital-at-home closer to hospital standards,” says Albert Siu of Mount Sinai, “is that we don’t want to recreate the hospital environment now in the home” — one in which Manuelita Romero’s walls are plastered with infection-control signs instead of her cherished religious relics, her fridge’s temperature adjusted for antibiotics instead of her vegetables, or one in which Bob Saltzman is restricted to the tiny space inside his trailer instead of his favorite spot outside. That, Siu warns, would “decrease some of the good things that we’re trying to accomplish with hospital-at-home.”In September, Rita Nelson, who is now 87 and lives with her niece’s family, was hospitalized for sepsis at Appalachian Regional Healthcare’s hospital in Hazard, in eastern Kentucky. After a week in the hospital, Nelson, who suffers from dementia, was not doing well. Her blood work had mostly returned to normal and she hadn’t spiked a fever in days, but she was more confused and hadn’t gotten out of bed in a week. She barely touched her meal trays. Her niece, Susan Johnson, wanted to take her home, but Nelson was still sick. Anywhere else in Kentucky, she would have had no alternative to staying in the hospital, but the medical center is part of a clinical trial being conducted by Harvard that enabled her to finish her treatment at home.In June, A.R.H., which includes 14 hospitals in Kentucky and West Virginia, rolled out a home-hospital trial at its largest site, a 300-plus-bed medical facility in Hazard, initiated by David Levine, the Brigham doctor. For more than a year, Levine and his team at Harvard’s Ariadne Labs helped A.R.H. set up its operation by sharing sample work flows, giving feedback on the protocols that A.R.H. staff members developed and guiding them through the process of applying for a C.M.S. waiver — which, he admitted, “is a very intimidating thing for rural hospitals.” A.R.H. also contracted with a company called Biofourmis to supply wearable monitoring devices. (Levine developed some of this technology, so his research lab may reap future royalties.)Jody Vandock, 88, has been hospitalized multiple times for diverticulitis, an infection in the intestines, over the years. During a recent home-hospital stay, a severe allergic reaction to an antibiotic forced her back to the hospital, where “she did not want to go at all,” De Pirro says. After several days there, she returned home to finish the rest of her treatment.Kholood Eid for The New York TimesWhen the ambulance took Nelson from the hospital to her niece’s single-story, white stone house, situated on a very steep hill off a main road, two nurses, Valerie Frazier and Megan Lewis, were waiting in their Jeep outside. A hospital bed had already been delivered. As Nelson, pale with her steel blue eyes half-closed and crumpled on her side on a stretcher, was rolled into the house, the nurses unloaded their gear. They wheeled in a large yellow box, along with a black one; next, they brought in an oversize backpack and, finally, bottles of vanilla-flavored nutritional shakes piled on plates of food. A hefty emergency kit remained behind in their vehicle. According to Tammy Fugate, the program’s nursing director at the time, most nurses need about half an hour to settle new patients into beds on their hospital wards, but creating a hospital room in the home could require two hours.Immediately, Frazier had trouble making the wireless interconnection between Nelson’s Biofourmis patch and an iPad-like tablet. The patch, which resembles a slim flat bow tie and is affixed to one’s chest, monitors heart rate and rhythm, breathing, temperature and movements. This data would be sent continuously in real time through a tablet to her entire team, which included all her nurses, as well as her doctor and a nurse practitioner from the hospital. At night, Biofourmis’s nurses would monitor her remotely; A.R.H. didn’t have nurses to spare — nearly half of them were temps on travelers’ contracts — so they paid extra to Biofourmis for this service.Frazier peeled Nelson’s patch off, folded it into her pocket, then applied a new one. Unable to link it to the tablet, she finally called Biofourmis’s tech-support team, which helped her go through the family’s internet connection instead. Wi-Fi can be mercurial in Appalachia and other rural areas, so mobile wireless broadband is also on hand as a backup, if a patient’s residence lacks a connection.Infrastructure and geography are always more troublesome in rural places. Appalachia’s “hollers” — the hollows, or narrow valleys between mountains — can be tough to traverse even in favorable weather. When catastrophic floods hit the region in late July, the A.R.H. program had to stop for six weeks. “We tried to take some patients home, and there wasn’t a home to take them to,” Fugate says. As Frazier puts it: “How can you safely care for somebody in their home if they have no water? If they have no electricity?”Soon after the patch and the tablet were connected, Nelson’s IV stopped working. Her niece worried that she would need to return to the hospital. It took several pokes for Lewis to place a new IV in her right arm.A few minutes later, the tablet and Frazier’s phone started ringing: Did Nelson fall down? Because Frazier had folded the Biofourmis patch into her pocket, an alert had been sent out. Three people immediately checked in: the nurse practitioner, a Biofourmis nurse and the nurse coordinator for the trial.This oversight continued throughout the night. Around 9:30 p.m., Johnson received a video call on the tablet from a Biofourmis nurse. Nelson’s breathing rate had gone up — was she OK? (She was moving from the sofa to her bed. Everything was fine.) Then, close to 2 a.m., Johnson’s phone buzzed; Nelson’s heart rate had dropped — how was she? (She was sleeping comfortably.) Though the tablet was in Nelson’s bedroom, only Johnson’s phone rang, so as not to awaken the patient. “It made me feel more secure, that’s how close they were monitoring her,” Johnson said. “I can sleep easier now because if she moves, I know they’re going to know it.”Early the next morning, when Lewis returned, Johnson opened the door in her pajamas. Before she could say anything, Lewis acknowledged Nelson’s slow heart rate overnight. She reassured Johnson that she thought Nelson was fine, but she would check with the doctor. Lewis asked if Nelson ate dinner. “Lord, let me tell you,” Johnson replied, before rattling off Nelson’s meal: chicken, hush puppies, coleslaw and an ice-cream bar. Johnson was very pleased: “She had hardly eaten nothing in the hospital.”Nelson was still asleep, her bed warmed by a heating pad that her niece had slipped underneath the covers. Family photos of Nelson’s parents and her 14 brothers and sisters lined a nearby desk. “Where am I?” she asked when she awoke, rosy-cheeked. Sometimes she thought she was in the hospital; sometimes she thought she was in her old house in Michigan.De Pirro and Lori Morgan, a registered nurse, treating Vandock. “She was 100 percent happier at home with her dogs, which is very therapeutic for her,” De Pirro says.Kholood Eid for The New York TimesFor the first time since she fell ill, Nelson sat up by herself in bed, then took a few steps using her rolling walker. She climbed onto the kitchen counter stool with Johnson’s help and took her coffee piping hot, the only way she’ll drink it. With her niece’s encouragement, she also sipped a nutritional shake. In the hospital, she didn’t want to eat, Johnson intuited, because the whole family was unable to convene there for meals. Nelson offered her own explanation: “You don’t need to eat a lot of stuff when you just lay.”Lewis listened to her heart and lungs and gave her IV antibiotics. She would be back that evening; she would monitor Nelson in the meantime through the patch. “If you need anything beforehand,” she told Johnson, “you just call us, OK?”When Nelson’s blood pressure ran high on another day, Frazier already had the remedy ordered by the doctor — it was in the emergency kit in her car. Later, Lewis inspected Nelson’s feet, scanning for the pressure ulcer that had started to form on her left heel during her stay in the hospital. But it was no longer pink and seemed to have vanished. “Not saying the hospital wasn’t taking care of her,” Johnson said — but she just knew her aunt would do better at home.Most rural Americans, though, won’t be getting hospital care at home any time soon. In addition to the $190,000 funding from the Harvard study, A.R.H. put in close to a million dollars to jump-start its operations. Its hospital in Hazard is big and part of an even bigger system, which all but ensures its economic viability. For a tiny rural hospital at risk of closure, keeping its doors open while also caring for patients at home is not realistic, according to Harold Miller, the Center for Healthcare Quality and Payment Reform president, who has extensively studied and been consulted on rural hospitals. “If they don’t have enough patients to make an inpatient unit viable, they sure as hell don’t have enough to make a hospital-at-home program viable.” He adds, “Why you have a hospital to begin with is because you can manage more patients in a hospital than you can in multiple home sites, and the farther apart those homes are, the more challenging it is.” That describes the landscape of much of rural America.The same staffing frustrations that trouble rural hospitals are only magnified when care moves into homes. Fugate learned how arduous it can be when she hired six separate nurses, and every one of them failed to show up because they got better offers or realized they didn’t want to be in patients’ houses after all. Nurses aren’t the only workers in short supply. If paramedics fill in, then a rural community may not have anyone to respond to 911 calls. For small rural facilities, hospital-at-home “would be cost-prohibitive, human-resource-prohibitive,” says Maria Braman, A.R.H.’s chief medical officer, now that she’s had experience building one. “They’re barely making it,” she says. “Taking on a project like this would be impossible.”For now, it seems hospital-at-home will share the fate of American health care generally: It’ll go to where the money is. From multibillion-dollar medical centers, hospital-at-home will flow to those in metro areas, cities and towns, eventually making its way to patients near larger rural hospitals and then — maybe, if ever — trickling down to the people who, cruelly, already live the farthest from any hospital. What would it take to redirect this path? “If we as a society think that hospital-at-home services are in fact desirable,” Miller says, “then they need to be paid for and covered — at whatever the cost of it is.”That evening, in Hazard, Nelson, her snow white pixie hair coifed, sat on the couch in a cable-knit cardigan with Johnson and her husband, another niece and a grandniece gathered around her. The nightly news hummed from the TV. The savors from a supper crackling in a frying pan drifted in from the kitchen. The dog hopped onto Nelson’s lap. Nelson didn’t ask where she was.Helen Ouyang is a physician, an associate professor at Columbia University and a contributing writer. Her work has been a finalist for the National Magazine Award. She last wrote about how virtual reality is being used to help ease chronic pain. Kholood Eid is a documentary photographer, filmmaker and educator based in New York and Seattle who is known for her intimate portraiture. In 2020, she was a joint recipient of the Robert F. Kennedy Journalism Award for Domestic Print for the Times series “Exploited.”

Read more →

Can Virtual Reality Help Ease Chronic Pain?

Listen to This ArticleAudio Recording by AudmTo hear more audio stories from publications like The New York Times, download Audm for iPhone or Android.After an hour-and-a-half bus ride last November, Julia Monterroso arrived at a white Art Deco building in West Hollywood, just opposite a Chanel store and the Ivy, a restaurant famous for its celebrity sightings. Monterroso was there to see Brennan Spiegel, a gastroenterologist and researcher at Cedars-Sinai who runs one of the largest academic medical initiatives studying virtual reality as a health therapy. He started the program in 2015 after the hospital received a million-dollar donation from an investment banker on its board. Spiegel saw Monterroso in his clinic the week before and thought he might be able to help alleviate her symptoms.Monterroso is 55 and petite, with youthful bangs and hair clipped back by tiny jeweled barrettes. Eighteen months earlier, pain seized her lower abdomen and never went away. After undergoing back surgery in September to treat a herniated disc — and after the constant ache in her abdomen worsened — she had to stop working as a housecleaner. Eventually, following a series of tests that failed to reveal any clear cause, she landed in Spiegel’s office. She rated her pain an 8 on a 10-point scale, with 10 being the most severe. Chronic pain is generally defined as pain that has lasted three months or longer. It is one of the leading causes of long-term disability in the world. By some measures, 50 million Americans live with chronic pain, in part because the power of medicine to relieve pain remains woefully inadequate. As Daniel Clauw, who runs the Chronic Pain and Fatigue Research Center at the University of Michigan, put it in a 2019 lecture, there isn’t “any drug in any chronic-pain state that works in better than one out of three people.” He went on to say that nonpharmacological therapy should instead be “front and center in managing chronic pain — rather than opioids, or for that matter, any of our drugs.”Virtual reality is emerging as an unlikely tool for solving this intractable problem. The V.R. segment in health care alone, which according to some estimates is already valued at billions of dollars, is expected to grow by multiples of that in the next few years, with researchers seeing potential for it to help with everything from anxiety and depression to rehabilitation after strokes to surgeons strategizing where they will cut and stitch. In November, the Food and Drug Administration gave authorization for the first V.R. product to be marketed for the treatment of chronic pain.Spiegel, who has the slim build of someone who runs marathons (he has finished 18 of them), fastened a black V.R. set onto Monterroso’s head. It was wired to a computer, behind whose monitor sat Omer Liran, a psychiatrist and self-taught programmer who created the virtual worlds for this use. “The beauty of doing everything here is that I can very quickly change things with patient feedback,” Liran told me. “If we outsourced it, it would be pretty much impossible,” he said — or at least slow and expensive.The week before, Spiegel and Liran started collecting various biometric data from patients while they were in virtual reality. Liran’s computer showed what was happening to Monterroso’s heart and eyes and to her cognitive load, or mental effort, while a two-dimensional version of what she was seeing in the headset played on another screen. Monterroso sat in a plastic chair under fluorescent lights, but in virtual reality she stood on a footbridge in a lush forest. As she looked around at the giant trees, she trembled, and tears suddenly started streaming down her face. Her cognitive load, shown as a pink line on the computer, started to increase.“I feel like I’m there with my son,” she said in Spanish. Her 21-year-old son died in a car accident in June. They loved visiting Yosemite together, and in these virtual woods, she felt as if she were hiking with him again. Spiegel reassured her that such intense reactions are very common, then leaned over to whisper to me, “She’s doing her own therapy right now.”‘I’ve tried breathing exercises before, but this is much more relaxing. I don’t have pain in my stomach now.’As her tears dried, Monterroso slowly moved her head to look over a menu of choices. Selecting a beach-scene option with her gaze, she found herself beside a placid sea, under a brilliant blue sky. A mandala moved toward and away from her, syncing her breathing rates to a relaxation-inducing tempo. Her cognitive load and heart rate slowed, and her pupils became less dilated, all signs of relaxation. After a while, she headed to the mountains, where goats trotted by. “Welcome back,” Spiegel said as Monterroso removed the headset. He pulled up some of her measurements on the computer monitor. He explained that larger pupils, for example, indicate stress. “In the forest, they’re big.”“Because my emotions were very strong then,” Monterroso replied.“In the mountains, the pupils were smaller because you were relaxed,” Spiegel continued, his finger tracing a downward-sloping line on the screen. “I’ve tried breathing exercises before,” she said, “but this is much more relaxing.” She rubbed her abdomen. “I don’t have pain in my stomach now.”Next, Monterroso entered another virtual environment that Liran built specifically for patients with chronic gastrointestinal symptoms. In this setting, unlike the previous one, Monterroso used hand controls. Inside a virtual clinic, a robot named Maia — short for “mixed-reality artificial-intelligence assistant” — guided her to a young blond woman, who expressed frustration with abdominal symptoms. Monterroso examined the patient with her virtual hands, placing a stethoscope on her stomach to listen to the sounds of digestion. Maia explained how the brain and the gut work together. As she spoke, an image of a brain popped up, connected to intestines by a yellow flashing line. When the brain became stressed, it turned fuchsia in color, and the yellow line to the gut metamorphosed into a stream of fire. A pounding heart appeared. Because the program is in English, Spiegel translated Maia’s speech into Spanish: “When you have a lot of stress, the heart beats faster, the intestines can move faster and oxygen in the body goes to the brain, away from your intestines.”“This really helped me to understand how the brain and the intestines work together, because after the accident of my son, I’ve been very sad,” Monterroso told Spiegel after her V.R. session. She looked around the room, seemingly surprised to see everyone. “I didn’t even notice the people here,” she said.“That’s because people can’t live in two realities at once,” Spiegel said. He was describing V.R.’s “unique ability to convey a sense of just ‘being there,’ wherever there happens to be,” as he puts it in his book “VRx: How Virtual Therapeutics Will Revolutionize Medicine.” “All of its revolutionary potential tumbles out of its ability to compel a person’s brain and body to react to a different reality.” Humans may use roughly 50 percent of our brains in visual processing, Spiegel writes, so “bombard the eyes with spectacular and dynamic visions, and next thing you know, those three billion neuronal firings per second will ricochet through half the brain to process the overwhelming load of visual data.” In this reality, Monterroso no longer experienced pain. “What we saw today with Julia was like a ‘cyberdelic,’ as if she took psilocybin,” Spiegel told me, referring to the hallucinogen. “She had explosive insights into how to modify her own life.” Her amygdala was “on fire,” he added, referring to the almond-shaped structure in the brain that processes emotions. The real-time biodata helped her connect the dots between brain and body, while Maia taught her how she could potentially turn the pain off. Even though Spiegel tried to explain all this to her the week before, she did not grasp it until she tried V.R. “I almost don’t even care what the mechanism is of how it’s working,” Spiegel told me. And indeed, its impact on chronic pain still isn’t fully understood. What really matters to him is the answer to his question: “Is it clinically working or not?”Illustration by Deanne CheukI began looking into novel treatments for chronic pain because, as an emergency-room doctor, I’ve long grappled with caring for patients at the extremes of persistent suffering. I’ve seen what happens when our medical treatments turn deadly. Years after telling a man that his son had died of an opioid overdose — which resulted from an addiction to prescription painkillers following foot surgery — I can still hear his wails, and recall how they brought my hospital’s bustling E.R. to near silence.The opioid epidemic, an American tragedy, has no clear end in sight. Drug-overdose deaths, most of them from opioids, rose 30 percent during the first year of the pandemic. While illicit fentanyl is largely to blame, the health care system is also complicit in this harrowing statistic: At one point, 80 percent of those who were using heroin first misused prescription opioids. Patient-rated pain scores in siren red used to be a regular feature on my E.R.’s dashboard, having gained the same importance as other vital signs like oxygen levels and blood pressure — until they quickly disappeared after Purdue Pharma became implicated in the unethical marketing of opioids. The health care system, confronted with evidence that these drugs were being overprescribed and even harming some patients, then began cutting them off abruptly in some cases instead of tapering their use or offering alternative treatments.The patients who haunt me nearly as much as those who have succumbed to the opioid crisis are the ones I send away, often in as much pain as when they first arrived. When I meet patients with chronic pain in the E.R., they narrate their years of suffering, and I respond with remedies that I know — and they know that I know — they’ve tried before with no success. This is when I feel the most futility as a physician.Figuring out chronic pain can be mystifying for doctors. In M.R.I. studies of people’s spines, disc herniations have been found in half of those subjects who nevertheless report feeling no pain. Age-related degenerative findings also show little correlation with symptoms. Some patients with knee osteoarthritis continue to have pain after joint-replacement surgery. While chronic pain may flummox the usual scans and tests, the condition is very much real, causing immeasurable suffering.We have, at least, come to recognize that acute pain resulting from damage to tissues is not the same as chronic pain, which is now considered a distinct disease. How we came to this understanding can be traced back to a serendipitous experiment in London in the early 1980s. Before then, scientists knew that the brain has some control over pain, but that insight was mostly confined to the situations described by Patrick Wall’s and Ronald Melzack’s gate-control theory, which helps explain why, say, a person running from a house on fire may not realize that she sprained her ankle until she is a safe distance away. The brain, so intent on escaping the fire, shuts the gate, blocking pain signals coming up the spinal cord from the ankle. “You could close the gate,” says Clifford Woolf, a neurobiology professor at Harvard Medical School who worked in Wall’s lab, but “essentially there was nothing about the opposite possibility — which is that the brain, independent of the periphery, could be a generator of pain.” Woolf was conducting his own experiment in Wall’s lab, applying painful stimuli to rats’ hind legs. The animals developed large “fields” of pain that could easily be activated months later with a light tap or gentle warmth, even in spots that weren’t being touched directly. “I was changing the function of the nervous system, such that its properties were altered,” Woolf says. “Pain was not simply a measure of some peripheral pathology,” he concluded; it “could also be the consequence of abnormal amplification within the nervous system — this was the phenomenon of central sensitization.” Before this discovery, he says, “the feeling was always pain is a symptom that reflects a disease, and now we know that pain often is a consequence of a disease state of the nervous system itself.” Some ailments, like rheumatoid arthritis, can exhibit both peripheral pathology and central sensitization. Others, like fibromyalgia, characterized by pain throughout the body, are considered solely a problem of the central nervous system itself.A better grasp of how chronic pain changes the central nervous system has emerged since Woolf’s experiment. A.Vania Apkarian’s pain lab at Northwestern University found that when back pain persists, the activity in the brain shifts from the sensory and motor regions to the areas associated with emotion, which include the amygdala and the hippocampus. “It’s now part of the internal psychology,” Apkarian says, “a negative emotional cloud that takes hold.”The brain itself morphs. Patients with chronic pain can show a significant loss of gray matter in the prefrontal cortex, the attention and decision-making region of the brain that sits behind our foreheads, as well as in the thalamus, which relays sensory signals; both areas are important in processing pain. Excitatory neurotransmitters increase, and inhibitory ones decrease, while glial and other immune cells drive inflammation; the nervous system, unbalanced, magnifies and prolongs the pain. The system goes haywire, like an alarm that keeps blaring even when there’s no threat, even when the pain isn’t protective anymore. Instead, it just begets more pain — and the longer it lasts, the more deeply systemic it becomes and the harder it is to resolve.There’s a popular saying in neuroscience that as neurons fire together, they begin to wire together, an example of neuroplasticity in action. But if our brains really are plastic, what is shaped there can be reshaped. Therapies that target the brain instead of the aching back or the sore knee — whether through psychology, drugs, direct stimulation of the brain or virtual reality — in theory could undo chronic pain. In the 1990s, Hunter Hoffman, a cognitive psychologist at the University of Washington, began to use V.R. to provide relief to burn patients who were having their dressings changed — an excruciating ordeal that is difficult to medicate. “Nobody was using virtual reality to reduce the pain of patients before us,” he says. In his V.R. program, called SnowWorld, patients who tumbled through the wintry scene, chucking snowballs at penguins, reported that their relief was similar to what they got from intravenous opioids. Brain scans confirmed these findings: V.R. and opioids each resulted in remarkable reductions in neural activity in pain-related areas. Unlike most drugs and surgical procedures, V.R. has far fewer side effects — mostly nausea and motion sickness. Headsets now cost a fraction of what they once did, and graphics are markedly improved, resulting in more immersive experiences and fewer potential side effects. What’s more, Hoffman says, “all the major computer companies are pumping billions of dollars into virtual reality as a kind of internet” — what Mark Zuckerberg called an “embodied internet” when he announced last fall that Facebook was becoming Meta. A few months later, Microsoft unveiled plans to acquire Activision Blizzard to “provide building blocks for the metaverse,” the company said. The downstream effects of all this technological ferment, Hoffman predicts, is that V.R. therapies, powered by private-sector investments, will swiftly develop into a standard treatment for pain.On Aug. 8, 2016, Robert Jester, a retired high school biology teacher in Greenport, N.Y., who was moonlighting as a chimney sweeper — both to support his family and to enjoy the magnificent views — drove to a nearby neighborhood for a quick job. The ladder he took was too short, but it seemed like a simple sweep, so he decided to go ahead with the work anyway. He climbed to the top, the ladder slipped — and he fell to the hard ground below. The pain in his back was so intense that he couldn’t make out the rescue workers bending over him; he could see only white light.A broken spinal cord means he can’t walk today, and his legs constantly feel as if they’re submerged in boiling water; frequently, they also feel as though knives are stabbing them up and down their length. He fractured his molars from clenching down during these episodes. The first year after his accident, the pain was so unbearable that he almost enacted his step-by-step suicide plan a dozen times. Opioids softened the agony, but they also changed his mood. He stopped telling jokes. And if he no longer had his sense of humor, he thought, what was the point of living?Before the accident, Jester got his students so excited about biology that they wanted to work on their science projects long after school, frustrating the custodians who were trying to clean his classroom in the evening. During fire drills, his students would form a conga line, chanting, “D-N-A deoxyribonucleic acid.” He also volunteered as a tutor to kids in town. One of them had a father named Bob McInnis, whom Jester met while cleaning the family’s chimney. McInnis happened to have seen an internet video about a company in Los Angeles called AppliedVR. At the time, in the spring of 2017, AppliedVR was focused on treating anxiety and acute pain in those who had to undergo hospital procedures, especially children. McInnis went to the company’s website and filled out a general contact form with information about Jester’s situation. “Is there anything that your device might be able to do to help him?” he typed. “Just thought I’d throw it out, given how much pain he’s in.” He didn’t expect to hear back. Three hours later, an email from Josh Sackman, one of the company’s founders, arrived in McInnis’s inbox. A headset soon appeared in Jester’s mail.Sitting in a plush brown recliner, his beef stroganoff dinner on a tray before him, Jester tried V.R. for the first time. He got so caught up viewing a farm scene that he tried to shoo away a cow that came over to lick him — and knocked the noodles all over his living-room wall. He was hooked. Next, he flew with the Wright brothers, controlling the plane by looking in different directions. (AppliedVR has stopped using this module.) Jester realized that he was so focused on keeping the plane upright that he was no longer dwelling on his pain anymore. He wondered if he could use V.R. to distract himself and reduce his reliance on OxyContin and other pain medications — and eventually stop altogether.He started charting his opioid use in a little blue notebook, while continuing daily V.R. sessions. After two months, he was off narcotic painkillers. Now, Jester told me recently, “I use the training right away when the pain comes on.” He squeezed his eyes closed and breathed in deeply. “I can refocus myself for a minute,” he said, imagining one of the special V.R. plants whose bare branches become full of leaves when his breathing is slow and steady, as detected by a sensor on the headset.When Sackman and his co-founder, Matthew Stoudt, heard about Jester’s success with V.R. and opioid tapering, they redesigned their product: EaseVRx — renamed RelieVRx in February — would provide therapy for chronic pain. Beth Darnall, a psychologist and director of Stanford’s Pain Relief Innovations Lab, is the company’s chief science adviser. She describes the breath-fed tree as a way for visual elements to “reflect back to the user the changes that are occurring in their own physiology.” She adds, “It’s a powerful way to teach principles and concepts that extend well beyond what we do in traditional didactic cognitive behavioral therapy.” The sort of biometric data that Spiegel and Liran captured with their graphs are here distilled into an aesthetically appealing format that delivers immediate, actionable feedback without interrupting a patient’s immersion in virtual reality. Because Jester left his headset at the facility where he did physical therapy, he was unable to use it for more than a year during the pandemic. But he discovered that he had retained the lessons he learned in V.R. This is the kind of lasting, real-world effect that V.R. experts see as their ultimate goal. After all, as Hoffman, the University of Washington professor, points out, “We can definitely reduce your pain while you’re in the helmet, but you can’t stay in there all day.”RelieVRx also has modules that prompt patients to redirect their attention through game play or by allowing scenes — waves washing onto a sunny coast, say — to soothe their nervous systems. The average session lasts seven minutes, and patients are directed to do just one a day for eight weeks. Unlike the sort of V.R. that’s popular in gaming, RelieVRx tracks only patients’ head movements, meaning Jester can’t go up to the tree and grab a branch (or chase cows away). The product is designed to be easier to use than an iPhone — you just strap on the headset and press the power button. Todd Maddox, a cognitive neuroscientist and AppliedVR’s vice president for research and development, explains how RelieVRx works with an example: “I am rewarding you with a tree that flourishes for generating an appropriate breathing pattern. I didn’t tell you to read a PDF or count in your head.” But by using V.R. to engage the brain in experiential learning, he says, “I have just set you on a path for behavioral change.”To date, AppliedVR has raised more than $70 million. Much of this money has been directed toward product development and clinical trials. A recently published study by researchers affiliated with the company, for which they recruited subjects during the pandemic through Facebook ads and pain organizations, reported an average drop in chronic back pain by nearly 43 percent for the RelieVRx group compared with 25 percent for the control group. For those who used RelieVRx, pain also interfered less with their activity and sleep. Three months after the last V.R. session, these gains were mostly found to endure (and sometimes they persisted for six months). If these numbers hold up, they would indicate that users had retained the coping skills they learned inside the virtual world, as Jester did. Maddox hypothesizes that the program “alters structure and function of the brain.” While acknowledging that he does not have concrete evidence, he says, “You don’t get changes in patient-reported outcomes without changes in the brain.”In mid-November, the F.D.A. gave AppliedVR authorization to market what is now RelieVRx for chronic lower-back pain — a regulatory first that may pave the way for the agency to OK similar V.R. products — in large part because the side effects are minimal compared with those of pharmaceuticals. “Medical-device regulation is not drug regulation,” a senior official at the F.D.A. told me. “For V.R., some of those technologies and some of the uses we need to see before they can be marketed. But we can also envision and imagine there are some where that’s not necessary.” AppliedVR was founded by two entrepreneurs with expertise in business and marketing, not health care veterans. Sackman claims their backgrounds give them an advantage. The first questions he says he asked when he learned about V.R. were: “If this stuff is so powerful, why is it sitting in an academic lab? Why don’t more people know about it? Why aren’t people using this in clinical practice?” He answered the questions himself: “It’s because there aren’t people productizing it. There’s not a business model.” Liran, at Cedars-Sinai, concedes the point. “We aren’t businessmen,” he told me. He and Spiegel intend to keep their own V.R. products in house. “The way we make money here is grants — that’s our currency,” Spiegel says. “I don’t want this to be suddenly sold and licensed commercially, and now I can’t get an N.I.H. grant.” Apart from a small one-time payment in 2016, Spiegel says, he doesn’t earn money from AppliedVR, but he occasionally advises the company, and he uses its products in some of his federally funded research. He says that is mainly because there is “nothing better right now” for chronic pain. (Cedars-Sinai itself, which first invested in AppliedVR six years ago through the hospital’s tech incubator, may someday opt to commercialize its own V.R. efforts.)Still, Spiegel recognizes the value of start-up funding and the freedom that comes with it. The initial $1 million directed toward some of his work helps him and Liran take V.R. to the bedsides of hospital patients. That sort of funding, Spiegel says, gives his group “extra support and flexibility to be innovative” — including the creation of their own V.R. programs and making them available without cost.I met one of these hospitalized patients, Misty Williams. A 38-year-old chef who has long suffered debilitating pain episodes caused by sickle-cell disease, Williams relies on Dilaudid, a strong narcotic — but not while she’s catering, because “if anything happens on the job, they’re going to ask you what you’re taking, and so I don’t,” she says. After her inpatient V.R. session, she concluded that the headset was better than Dilaudid. What would be most helpful, she pointed out, would be using V.R. during her breaks at work. Spiegel’s program helped her during her hospitalization, but it won’t do so after she goes home.AppliedVR is considered the pioneer and the company that is most likely “furthest along in getting devices to patients,” according to Amanda DiTrolio, a health care technology analyst at CB Insights, but several other companies are also closing in. Karuna Labs, a start-up based in San Francisco, has created a hybrid model that mixes V.R. with aspects of telehealth. “We’re neuroscience people” with “whiz-bang technology,” says Lincoln Nguyen, its founder. He is reluctant, however, to call his firm a V.R. company, because he considers coaching sessions to be central to what Karuna does. Patients are paired with a pain coach, who makes weekly video calls to supplement the self-guided V.R. modules that patients go through daily for three months. Jon Weinberg, Karuna’s chief operating officer, emphasizes that the human engagement is essential. The coaching curriculum falls under the purview of Howard Schubiner, director of the Mind Body Medicine Center at Ascension Providence Hospital in Michigan and a clinical professor at Michigan State University’s College of Human Medicine, and Kristine Beebe, Karuna’s lead pain coach and physical therapist. Schubiner is a protégé of the late John Sarno, a controversial pain doctor who taught patients that their pain was caused by repressed emotions. Schubiner recognizes the limitations of Sarno’s work and what he got wrong — being angry at your mother about your childhood isn’t likely to cut off blood flow to your back — but he maintains that treating chronic pain requires a rewiring of the brain, which can involve recognizing emotions and difficult life events. “Not some kind of woo-woo New Age thing,” Schubiner told me. “This is just straight neuroscience.” Schubiner, who is not involved in the V.R. aspect of Karuna’s program, instructs the patients in his own clinic in Michigan to imagine that they are taking part in activities without experiencing pain — like the athlete visualizing the perfect shot — so that they engage the corresponding but dysfunctional neurons. Karuna tries to do the same thing by using V.R. instead of requiring patients to rely on their imagination. In an interactive virtual setting — Karuna’s head sensors and hand controls determine how the body moves — patients with back pain, say, might be asked to bend as far as they can without discomfort, then make both their body and their avatar gradually increase their spinal flexion. Archery games help patients recover movement in their back (as they pick up arrows) or their shoulders (as they draw back the bowstring). In other modules, designed to facilitate the resumption of routine tasks, patients push around a virtual vacuum that cleans up colorful stars. The patients’ performance is transmitted to their coach.Seeing themselves perform this novel action, in an unfamiliar environment that has no associations with pain, seems to create new neural connections.Karuna is based on existing chronic-pain treatments, though some of the company’s explanations for how V.R. trains the brain are more heuristic than settled science. “We don’t have any hypotheses born in V.R.,” Weinberg says. According to Nguyen, the brain, transported to a different world in V.R., learns to stop associating routine motions with the usual pain. “I’ve seen the body moving in V.R. in ways that it can’t move in real life,” he told me. “You’re tricking your brain, using the visual system to move more, so that we have bottom-up, top-down synergistic effects that can help people to change.” If you can vacuum in virtual reality, then maybe you can vacuum in your living room too.Karuna also uses mirror therapy to trick the brain; this is how Nguyen first became interested in V.R. and chronic pain. Nguyen discovered it as an adolescent when he was looking for remedies for his father, who was in extreme pain after two debilitating strokes. The therapy was invented in the 1990s by V.S. Ramachandran, a neurologist, to treat phantom-limb pain, a phenomenon in which someone who has lost a leg or an arm still feels pain in the missing limb because the brain continues to perceive it as being present but also in an abnormal state. Ramachandran would place the arm of an amputee — or a stroke patient, in the case of someone like Nguyen’s father — into an open box with a mirror down the middle so that the sufferer, peering down through the top, saw the reflection of an intact, functioning arm on the affected side. Eventually, the thinking goes, the visually dominated brain sees a normal, healthy limb and reduces the pain signals — a crude form of virtual reality.In chronic pain, the body part that hurts may be undamaged and even seem healthy; what’s altered is the area of the brain that corresponds to its anatomical location. Karuna extends the idea of mirror therapy so that patients not only see their afflicted body part as healthy and pain-free in virtual reality; they also get to move it in complex ways. In one module, patients pick up lotus flowers with their healthy arm and toss them into a serene infinity pond surrounded by mountains; the V.R. mirrors the action but shows the opposite arm doing the motions. Seeing themselves perform this novel action, in an unfamiliar environment that has no associations with pain, seems to create new neural connections that eventually help repair the dysfunctional parts of their brains.At times, Karuna’s V.R. program exaggerates bodily movements, so patients see themselves moving more extensively in the virtual world than in actuality; this further disrupts their brains’ predictive coding — or what they expect to happen when they move. If the brain predicts that an action will be painful, then “it’s going to send that threat signal out ahead of time,” Nguyen says. But if people experience themselves maneuvering more easily and with greater range in V.R., then their brains may begin to recognize that increased movement as safe — and, Nguyen hopes, eventually pleasurable. To that end, patients also score points, accompanied by lights and dings, as in video games, in order to activate the reward centers in their brains. “We’re not trying to turn you into a zombie that doesn’t experience pain,” Nguyen says. “But at some point, the brain has gotten so good at making this pain signal. It’s very vigilant, constantly looking for danger signals.” “There’s no point in developing a technology just because it’s cool,” says Leonardo Angelone, who heads a program at the National Institute on Drug Abuse that oversees, among other things, F.D.A.-regulated medical devices. If V.R.-therapy companies can’t get their products onto patients’ heads, it doesn’t matter what the machinery can do. That means a lot of people — would-be individual users as well as decision makers in the broader health care industry — will need to have confidence in the technology. When Carol Dhainin heard about V.R. as a therapy for chronic pain, she thought she “would laugh in the doctor’s face if they gave this B.S.” Dhainin has struggled with chronic pain for more than 15 years, following a series of dislocations of her kneecap. The pain spread, until eventually she was diagnosed with fibromyalgia. She is 50 and has had 28 operations. She takes opioids around the clock, as well as several other medications, to dampen her symptoms. After she tried physical therapy, she was so exhausted that she slept for 10 days, setting her alarm to wake her every few hours to take her pills. “When you’re in a full flare and you’re rocking and crying into sleep in bed and your pain meds don’t work, virtual reality is not going to do squat,” Dhainin says. A tech-driven solution like V.R. can seem insulting to someone who feels that she has tried it all. “To see someone say, ‘Oh, we’ll give you V.R. and teach you to regulate your breathing’ — I’m like, ‘Didn’t you think I tried that already?’” Other skeptical reactions include preferences for the convenience of pills over the encumbrance of headsets, or fears that the widespread prescribing of V.R. will mean losing access to painkillers. Nicole Hemmenway, the chief executive of the U.S. Pain Foundation, views V.R. favorably — the more tools available, the better — but she recognizes that chronic-pain patients, who may feel that they have long been ignored by the medical community, now also face stigma and restrictions in response to the opioid epidemic. “There is always a fear that something else might come in the way of the treatment you’re currently on,” Hemmenway says.Of course, this assumes that medical providers will eventually embrace the technology. When I visited Cedars-Sinai, Spiegel had not yet been able to get the E.R. staff there to adopt virtual reality. I wasn’t surprised. The E.R. can be crushingly busy, and it’s a place where expensive medical equipment often gets damaged or lost; any extra bedside therapy feels like a significant burden in a system that is already overwhelmed. In this setting, V.R. seems to be one more time-consuming fantasy. Even in less intense circumstances, some doctors worry, V.R. could exclude those who don’t speak English or who are disadvantaged and unable to get the latest technology. In AppliedVR’s study of lower-back pain, nearly all the participants were white and had at least some college education.If doctors do start prescribing V.R., there’s another hurdle to clear: Who will pay for it? Affordable access to V.R. is Hemmenway’s biggest worry about the future of the technology. F.D.A. clearance is most likely necessary for the widespread adoption of any V.R. product; a spokesperson for one major insurer told me that the company wouldn’t even consider reimbursement without the F.D.A.’s authorization. Payers also want to see clinical trials demonstrating efficacy and economic analyses showing that V.R. can save money by keeping patients out of the hospital and cutting down on expensive tests and treatments. This is one reason AppliedVR says it prioritizes conducting studies.Though RelieVRx has been authorized by the F.D.A., insurers still don’t have to cover its cost. The company hopes that by packaging it as a single product, one that combines software and hardware, its resemblance to traditional medical equipment will lead to its acceptance by the Centers for Medicare and Medicaid Services, which currently does not cover V.R. services. That could change soon: In February, the C.M.S. approved a code for F.D.A.-cleared software for behavioral therapy, and a code is usually needed before reimbursement is considered; a month later, a bill was introduced in Congress that would push Medicare to cover prescription digital therapeutics. Private insurers determine their own policies, but the C.M.S. tends to set the standards.AppliedVR decided early on that if its product is going to be used like a drug or a device, it needs to function within the current health-coverage environment. “It needs to be prescribed by doctors and paid for by insurance,” Sackman says, “or else this will be on the fringes for people who can afford cash pay or believe in alternative medicine.”Workers’ compensation insurers, which have strong incentives to help patients return to their jobs, already provide reimbursements to Karuna, as does the Department of Veterans Affairs. Weinberg, Karuna’s chief operating officer, is hoping to persuade companies to include Karuna in their benefit packages soon. The health care system has been slow to fully buy into V.R. because it’s so new, Nguyen says. “But our way in is: ‘Just try it out. What do you have to lose? You tried everything else.’”In January, as Covid cases soared again, a man in his late 50s with chronic back pain came into the E.R. where I work. His painkillers were no longer providing relief. He was unsure if they ever really helped, but everything seemed worse now, he said. He had been unable to travel; he was stuck in his apartment, in pain, his doctors’ appointments scrambled with each pandemic surge. I told him all I could do was order a different formulation of one of his medicines, a desperate and often useless step that doctors take when trying to alleviate chronic pain. But he had come with an idea of his own.“Have you heard of people using virtual reality for pain?” he asked me eagerly. “How can I get that?”Helen Ouyang is a physician, an associate professor at Columbia University and a contributing writer for the magazine. She has been a National Magazine Award finalist.

Read more →